| Laboratory Findings |
|
|
|
|
|
| Serum Albumin (g/dL) | 4.1 ± 0.5 | 4.2 ± 0.4 | 4.0 ± 0.6 | 0.4 | 0.392 |
| Hemoglobin (g/dL) | 13.5 ± 1.7 | 13.4 ± 2.0 | 13.7 ± 1.5 | 0.7 | 0.170 |
| eGFR (mL/min/1.73 m2) | 52.7 ± 15.8 | 52.9 ± 16.2 | 52.6 ± 16.1 | 1.0 | 0.019 |
| Uric Acid (mg/dL) | 6.6 ± 1.5 | 7.6 ± 0.4 | 5.6 ± 1.5 | 0.0003 | 1.822 |
| Total Cholesterol (mg/dL) | 221.8 ± 89.1 | 214.5 ± 55.7 | 229.0 ± 115.7 | 0.7 | 0.160 |
| LDL Cholesterol (mg/dL) | 136.6 ± 77.8 | 130.4 ± 41.3 | 142.7 ± 104.2 | 0.7 | 0.155 |
| HDL Cholesterol (mg/dL) | 51.6 ± 14.2 | 56.0 ± 16.7 | 47.2 ± 10.1 | 0.1 | 0.638 |
| Triglyceride (mg/dL) | 168.0 ± 84.0 | 140.4 ± 59.9 | 195.5 ± 97.4 | 0.1 | 0.681 |
| UACR (mg/g Cre) | 205.9 ± 373.1 | 263.5 ± 482.5 | 148.3 ± 225.9 | 0.5 | 0.306 |
| Concomitant drugs |
|
|
|
|
|
| Antihypertensive agents (%) | 66.7 | 66.7 | 66.7 | 1.0 | 0.000 |
| Antidyslipidemic agents (%) | 29.2 | 25.0 | 33.3 | 0.7 | 0.183 |
| Antidiabetic agents (%) | 20.8 | 33.3 | 8.3 | 0.1 | 0.647 |
| Corticosteroids (%) | 20.8 | 25.0 | 16.7 | 0.6 | 0.205 |
| Immunosuppressing agents (%) | 12.5 | 8.3 | 16.7 | 0.9 | 0.256 |
| Diuretics (%) | 20.8 | 16.7 | 25.0 | 0.6 | 0.205 |
| Comorbidities |
|
|
|
|
|
| Hypertension (%) | 70.8 | 66.7 | 75.0 | 0.7 | 0.183 |
| HU (UA ≥ 7.1 mg/dL) (%) | 50.0 | 100.0 | 0.0 | <0.0001 | - |
| Hypercholesterolemia (%) | 41.7 | 41.7 | 41.7 | 1.0 | 0.000 |
| Hypertriglyceridemia (%) | 75.0 | 58.3 | 91.7 | 0.1 | 0.836 |
| Diabetes mellitus (%) | 25.0 | 33.3 | 16.7 | 0.3 | 0.391 |